These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37266387)

  • 21. Intra-articular Administration of Allogeneic Adipose Derived MSCs Reduces Pain and Lameness in Dogs With Hip Osteoarthritis: A Double Blinded, Randomized, Placebo Controlled Pilot Study.
    Maki CB; Beck A; Wallis CCC; Choo J; Ramos T; Tong R; Borjesson DL; Izadyar F
    Front Vet Sci; 2020; 7():570. PubMed ID: 33110913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
    Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
    BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.
    Bertoni L; Jacquet-Guibon S; Branly T; Desancé M; Legendre F; Melin M; Rivory P; Hartmann DJ; Schmutz A; Denoix JM; Demoor M; Audigié F; Galéra P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosafety Evaluation of Equine Umbilical Cord-Derived Mesenchymal Stromal Cells by Systematic Pathogen Screening in Peripheral Maternal Blood and Paired UC-MSCs.
    Denys M; Léon A; Robert C; Saulnier N; Josson-Schramme A; Legrand L; Wimel L; Maddens S; Pronost S
    Biopreserv Biobank; 2020 Apr; 18(2):73-81. PubMed ID: 31904273
    [No Abstract]   [Full Text] [Related]  

  • 25. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
    Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
    Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
    Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
    Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparative Study of Biological Characteristics and Transcriptome Profiles of Mesenchymal Stem Cells from Different Canine Tissues.
    Zhan XS; El-Ashram S; Luo DZ; Luo HN; Wang BY; Chen SF; Bai YS; Chen ZS; Liu CY; Ji HQ
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
    Taguchi T; Borjesson DL; Osmond C; Griffon DJ
    Stem Cells Dev; 2019 Dec; 28(23):1562-1571. PubMed ID: 31588862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study.
    Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL
    Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
    Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
    Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.
    Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL
    Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue.
    Gao S; Jin Y; Ma J; Wang J; Wang J; Shao Z; Fan T; Zhang M; Chang D
    Stem Cell Res Ther; 2022 Jun; 13(1):252. PubMed ID: 35690871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
    Uccelli A; Laroni A; Ali R; Battaglia MA; Blinkenberg M; Brundin L; Clanet M; Fernandez O; Marriot J; Muraro P; Nabavi SM; Oliveri RS; Radue E; Ramo Tello C; Schiavetti I; Sellner J; Sorensen PS; Sormani MP; Wuerfel JT; Freedman MS;
    Lancet Neurol; 2021 Nov; 20(11):917-929. PubMed ID: 34687636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs.
    Ryu HH; Kang BJ; Park SS; Kim Y; Sung GJ; Woo HM; Kim WH; Kweon OK
    J Vet Med Sci; 2012 Dec; 74(12):1617-30. PubMed ID: 22878503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
    Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
    Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-articular Mesenchymal Stem Cell Therapy for the Human Joint: A Systematic Review.
    McIntyre JA; Jones IA; Han B; Vangsness CT
    Am J Sports Med; 2018 Dec; 46(14):3550-3563. PubMed ID: 29099618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
    Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
    Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.